EUVIMEDEUVIMED entdecken
Crossref

FormulationGPT Is Not a Formulator: Governing Generative Artificial Intelligence across Excipient Selection, Process Design, and Product Decisions

David Thompson, Sarah Mitchell, Rachel Adams, James Brown, Michael Lee

International Journal of Pharmaceutical Research and Allied Sciences · 2026 · 15 (1) · 75-84

DOI: 10.51847/p5svbmxcbk ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Research and Allied Sciences, 2026. Verfasst von David Thompson und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Generative artificial intelligence can retrieve, reorganize, and synthesize formulation knowledge, but fluent output is not equivalent to the situated expertise required to design a pharmaceutical product. Formulation decisions depend on dosage-form purpose, material attributes, excipient functionality, compatibility, stability, process conditions, scale, bioavailability, patient needs, and the quality of supporting evidence. This article develops an original, non-empirical governance architectu

Zitieren

APA

Thompson, D., Mitchell, S., Adams, R., Brown, J., & Lee, M. (2026). FormulationGPT Is Not a Formulator: Governing Generative Artificial Intelligence across Excipient Selection, Process Design, and Product Decisions. International Journal of Pharmaceutical Research and Allied Sciences, 15(1), 75-84. https://doi.org/10.51847/p5svbmxcbk

Vancouver

Thompson D, Mitchell S, Adams R, Brown J, Lee M. FormulationGPT Is Not a Formulator: Governing Generative Artificial Intelligence across Excipient Selection, Process Design, and Product Decisions. International Journal of Pharmaceutical Research and Allied Sciences. 2026;15(1):75-84. doi:10.51847/p5svbmxcbk

BibTeX
@article{Thompson2026,
  author = {Thompson, David and Mitchell, Sarah and Adams, Rachel and Brown, James and Lee, Michael},
  title = {FormulationGPT Is Not a Formulator: Governing Generative Artificial Intelligence across Excipient Selection, Process Design, and Product Decisions},
  journal = {International Journal of Pharmaceutical Research and Allied Sciences},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {75--84},
  doi = {10.51847/p5svbmxcbk}
}
Kostenlos starten →